tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Denali Therapeutics 9.143M share Spot Secondary priced at $17.50

The deal range was $17.00-$18.00. Goldman Sachs, JPMorgan, Morgan Stanley and Jefferies acted as joint book running managers for the offering.

TipRanks Cyber Monday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1